A NEW MEMORY SCALE FOR CLINICAL POPULATIONS WITH MILD TO MODERATE IMPAIRMENT

被引：0
|
作者：
RANDT, CT
BROWN, ER
OSBORNE, DP
TARTARO, TJ
JONES, S
GIANUTSOS, R
机构：
来源：
INTERNATIONAL JOURNAL OF NEUROSCIENCE | 1981年 / 12卷 / 3-4期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：200 / 201
页数：2
相关论文
共 50 条
  • [21] FDA: metformin safe in mild to moderate renal impairment
    Reactions Weekly, 2016, 1598 (1) : 3 - 3
  • [22] Pharmacokinetics of Vilazodone in Patients with Mild or Moderate Renal Impairment
    Boinpally, Ramesh
    Alcorn, Harry
    Adams, Marijke H.
    Longstreth, James
    Edwards, John
    CLINICAL DRUG INVESTIGATION, 2013, 33 (03) : 199 - 206
  • [23] Auditory filter nonlinearity in mild/moderate hearing impairment
    Baker, RJ
    Rosen, S
    JOURNAL OF THE ACOUSTICAL SOCIETY OF AMERICA, 2002, 111 (03): : 1330 - 1339
  • [24] Influence of mild and moderate hepatic impairment on axitinib pharmacokinetics
    Tortorici, Michael A.
    Toh, Melvin
    Rahavendran, S. V.
    LaBadie, Robert R.
    Alvey, Christine W.
    Marbury, Thomas
    Fuentes, Ernesto
    Green, Matthew
    Ni, Grace
    Hee, Brian
    Pithavala, Yazdi K.
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (06) : 1370 - 1380
  • [25] EFFECT OF MILD AND MODERATE HEPATIC IMPAIRMENT ON QUIZARTINIB PHARMACOKINETICS
    Zahir, H.
    Lasseter, K.
    Marbury, T.
    Rondon, J.
    Bermudez, Y.
    Gammon, G.
    Kamel, Y. Mostafa
    Said, N.
    Hsu, C.
    Abutarif, M.
    Zheng, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S20 - S20
  • [26] Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment
    David Schnell
    Susanne Buschke
    Holger Fuchs
    Dietmar Gansser
    Rainer-Georg Goeldner
    Martina Uttenreuther-Fischer
    Peter Stopfer
    Sven Wind
    Marc Petersen-Sylla
    Atef Halabi
    Rüdiger Koenen
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 267 - 275
  • [27] Pharmacokinetics of Rolapitant in Patients With Mild to Moderate Hepatic Impairment
    Wang, Jing
    Wang, Xiaodong
    Zhang, Zhi-Yi
    Arora, Sujata
    Lu, Sharon
    Kansra, Vikram
    JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 58 (05): : 686 - 693
  • [28] Pharmacokinetics of Vilazodone in Patients with Mild or Moderate Renal Impairment
    Ramesh Boinpally
    Harry Alcorn
    Marijke H. Adams
    James Longstreth
    John Edwards
    Clinical Drug Investigation, 2013, 33 : 199 - 206
  • [29] Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment
    Schnell, David
    Buschke, Susanne
    Fuchs, Holger
    Gansser, Dietmar
    Goeldner, Rainer-Georg
    Uttenreuther-Fischer, Martina
    Stopfer, Peter
    Wind, Sven
    Petersen-Sylla, Marc
    Halabi, Atef
    Koenen, Ruediger
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (02) : 267 - 275
  • [30] Effect of Mild or Moderate Hepatic Impairment on the Pharmacokinetics of Ozanimod
    Zhang, Peijin
    Hosein, Fareeda
    Yu, Kyungha
    Walker, Susan
    Syto, Mary
    Tirucherai, Giridhar
    Murthy, Bindu
    Tatosian, Daniel
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 976 - 976
12345